Illustration of the potential price action of InMed Pharmaceuticals.
This company is still not yet a profitable business according to its financials. As this would make sense, with only open marijuana market in the USA. Canadian still has not been decriminalized in either our country limiting the markets etc. And has been taking a bit longer then expected lately.
So this is not a good stock to sort of trade. Or purchase for short gains. but rather long term progress.
Going public in 2014 with a share price of $.15 Then hanging around $.4 or less for quite a while. Gained some interest. There will be sometime before some real progression, because the legal blocks of marijuana use; medically and req.
Buying more around 60cents. seems to be the buy zone for marijuana investors. That will be the ideal interest price for more potential buys for long term. Price has not returned below this point, in over a year.
Just so happen that price does go lower, and into the concerned level in red, It is then you will need to decide, how long are you into this idea. And are you capable of holding a further draw down. The company should release news pertaining to its difficulties for investors.
We know, this company isn't profitable yet, so keep that inmed, is still in its premature stages.
So really there is progress, as in marijuana investors are investing in this developement. Not really so that the business its self is doing well. So we keep that in mind until reports, and earnings come out and such for the health sector. Just the swing in price shows the interest, that investors are constantly waiting to buy at the new lows. Or potential lowest price.
Use this price chart to refer to where you maybe at this this idea.
IMLFF 52 Week Range .1770- 1.9500
This company is still not yet a profitable business according to its financials. As this would make sense, with only open marijuana market in the USA. Canadian still has not been decriminalized in either our country limiting the markets etc. And has been taking a bit longer then expected lately.
So this is not a good stock to sort of trade. Or purchase for short gains. but rather long term progress.
Going public in 2014 with a share price of $.15 Then hanging around $.4 or less for quite a while. Gained some interest. There will be sometime before some real progression, because the legal blocks of marijuana use; medically and req.
Buying more around 60cents. seems to be the buy zone for marijuana investors. That will be the ideal interest price for more potential buys for long term. Price has not returned below this point, in over a year.
Just so happen that price does go lower, and into the concerned level in red, It is then you will need to decide, how long are you into this idea. And are you capable of holding a further draw down. The company should release news pertaining to its difficulties for investors.
We know, this company isn't profitable yet, so keep that inmed, is still in its premature stages.
So really there is progress, as in marijuana investors are investing in this developement. Not really so that the business its self is doing well. So we keep that in mind until reports, and earnings come out and such for the health sector. Just the swing in price shows the interest, that investors are constantly waiting to buy at the new lows. Or potential lowest price.
Use this price chart to refer to where you maybe at this this idea.
IMLFF 52 Week Range .1770- 1.9500